| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P50 | author | Kristiina Aittomäki | Q29840622 |
| Heli Nevanlinna | Q29840669 | ||
| Sofia Khan | Q56551025 | ||
| Sajjad Rafiq | Q57320710 | ||
| Diana Eccles | Q61756107 | ||
| Jianjun Liu | Q68692572 | ||
| Carl Blomqvist | Q73625505 | ||
| William D Tap | Q90147379 | ||
| Rainer Fagerholm | Q114337469 | ||
| P2860 | cites work | Global cancer statistics | Q22241238 |
| Sequence-specific transcriptional corepressor function for BRCA1 through a novel zinc finger protein, ZBRK1 | Q24290549 | ||
| Degradation of Transcription Repressor ZBRK1 through the Ubiquitin-Proteasome Pathway Relieves Repression of Gadd45a upon DNA Damage | Q24653338 | ||
| STRING 8--a global view on proteins and their functional interactions in 630 organisms | Q24656073 | ||
| Gadd45 family proteins are coactivators of nuclear hormone receptors | Q28139453 | ||
| Common polymorphisms in the prostaglandin pathway genes and their association with breast cancer susceptibility and survival | Q28237788 | ||
| Antiestrogens, aromatase inhibitors, and apoptosis in breast cancer | Q28268250 | ||
| Systematic identification of trans eQTLs as putative drivers of known disease associations | Q28659854 | ||
| Identification of inherited genetic variations influencing prognosis in early-onset breast cancer | Q28943279 | ||
| A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in Japanese | Q28943542 | ||
| GenABEL: an R library for genome-wide association analysis | Q29614587 | ||
| The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups | Q29614700 | ||
| Annotation of functional variation in personal genomes using RegulomeDB | Q29614867 | ||
| HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants | Q29614906 | ||
| Prospective study of Outcomes in Sporadic versus Hereditary breast cancer (POSH): study protocol | Q33294128 | ||
| A re-annotation pipeline for Illumina BeadArrays: improving the interpretation of gene expression data | Q33516189 | ||
| A genome-wide association study of prognosis in breast cancer | Q33780746 | ||
| Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival | Q33828680 | ||
| Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer | Q33845160 | ||
| Pharmacogenomics of CYP2D6: molecular genetics, interethnic differences and clinical importance | Q34241858 | ||
| Transcriptome and genome sequencing uncovers functional variation in humans | Q34371227 | ||
| A genome wide meta-analysis study for identification of common variation associated with breast cancer prognosis | Q34744122 | ||
| CYP2D6 and tamoxifen: DNA matters in breast cancer | Q34993830 | ||
| Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancer | Q35020403 | ||
| Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials | Q35186747 | ||
| Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer | Q35749331 | ||
| Novel genetic markers of breast cancer survival identified by a genome-wide association study | Q35803492 | ||
| Longer-term outcomes of letrozole versus placebo after 5 years of tamoxifen in the NCIC CTG MA.17 trial: analyses adjusting for treatment crossover | Q35808358 | ||
| Matrix eQTL: ultra fast eQTL analysis via large matrix operations | Q35947630 | ||
| Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer | Q36328588 | ||
| Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial | Q36680024 | ||
| Mechanisms of endocrine resistance in breast cancer | Q36851417 | ||
| Gadd45a levels in human breast cancer are hormone receptor dependent | Q36881270 | ||
| Significant effect of polymorphisms in CYP2D6 and ABCC2 on clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients | Q36915143 | ||
| CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations | Q37524058 | ||
| Biological determinants of endocrine resistance in breast cancer | Q37585095 | ||
| BreastMark: an integrated approach to mining publicly available transcriptomic datasets relating to breast cancer outcome | Q37689788 | ||
| Antiestrogens and their therapeutic applications in breast cancer and other diseases | Q37807420 | ||
| Gadd45 in stress signaling, cell cycle control, and apoptosis. | Q38150639 | ||
| A combined analysis of genome-wide association studies in breast cancer | Q42676622 | ||
| Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen | Q43233449 | ||
| Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients | Q45097069 | ||
| Common germline polymorphisms in COMT, CYP19A1, ESR1, PGR, SULT1E1 and STS and survival after a diagnosis of breast cancer | Q45263043 | ||
| The shaping and functional consequences of the microRNA landscape in breast cancer. | Q50481028 | ||
| Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1. | Q53326612 | ||
| Population-Based Study of BRCA1 and BRCA2 Mutations in 1035 Unselected Finnish Breast Cancer Patients | Q57274822 | ||
| Familial breast cancer in southern Finland | Q57306234 | ||
| Altered expression of the ZBRK1 gene in human breast carcinomas | Q75332820 | ||
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4086-4096 | |
| P577 | publication date | 2015-05-11 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | Polymorphism at 19q13.41 Predicts Breast Cancer Survival Specifically after Endocrine Therapy | |
| P478 | volume | 21 |
| Q99609984 | Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer |
| Q45943221 | Breast cancer: The translation of big genomic data to cancer precision medicine. |
| Q38369233 | Deep sequencing reveals the mitochondrial DNA variation landscapes of breast-to-brain metastasis blood samples |
| Q49252742 | Meta-analysis of three genome-wide association studies identifies two loci that predict survival and treatment outcome in breast cancer. |
| Q64892938 | Mouse mammary tumor viral env sequences are not present in the human genome but are present in breast tumors and normal breast tissues. |
| Q38673841 | Potential prognostic value of clinical characteristics, hormone status and major depressive disorder in breast cancer |
| Q97883645 | SNPs in lncRNA Regions and Breast Cancer Risk |
Search more.